Protara Therapeutics News | Markets Insider

TipRanks 49d

TipRanks 50d

GlobeNewswire 50d

TipRanks 75d

GlobeNewswire 77d

TipRanks 87d

GlobeNewswire 88d

GlobeNewswire 121d

GlobeNewswire 136d

TipRanks 169d

Seeking Alpha 169d

TipRanks 257d

Seeking Alpha 260d

Seeking Alpha 262d

TipRanks 264d

Seeking Alpha 266d

TipRanks 317d

Seeking Alpha 317d

Seeking Alpha 354d

TipRanks 439d

Seeking Alpha 442d

GlobeNewswire 442d

InvestorPlace 471d

GlobeNewswire 500d

Benzinga 521d

GlobeNewswire 528d

GlobeNewswire 577d

Seeking Alpha 577d

GlobeNewswire 603d

GlobeNewswire 612d

GlobeNewswire 617d

GlobeNewswire 624d

Seeking Alpha 624d

GlobeNewswire 666d

GlobeNewswire 681d

GlobeNewswire 688d

GlobeNewswire 717d

GlobeNewswire 739d

GlobeNewswire 745d

GlobeNewswire 806d

GlobeNewswire 816d

Benzinga 829d

GlobeNewswire 829d

Benzinga 834d

GlobeNewswire 854d

GlobeNewswire 858d

GlobeNewswire 864d

Benzinga 878d

Benzinga 882d

Benzinga 883d